期刊文献+

高效液相色谱法测定帕米膦酸二钠中的β-丙氨酸 被引量:3

Analysis of β-alanine impurity for the quality control pamidronate disodium
下载PDF
导出
摘要 目的建立帕米膦酸二钠中β-丙氨酸的检测方法。方法采用高效液相色谱法,以Kromasil C18(250mm×4.6 mm,5μm)为色谱柱,以甲醇-0.01 mol/L磷酸二氢钾缓冲液(用氢氧化钠调节pH值至7.0)(体积比30∶70)为流动相,流速为1.0 mL/min,检测波长为360 nm。结果β-丙氨酸的质量浓度在3-18μg/mL范围内与峰面积呈较好的线性关系,回归方程为y=0.0445x+0.2010,r=0.998 6;平均回收率为99.1%,RSD=1.9%。结论该法简便、灵敏度高,可用于帕米膦酸二钠中β-丙氨酸的质量控制。 Objective To establish an HPLC method for analyzing β-alanine impurity in the product of pamidronate disodium. Methods Samples were analyzed on a Kromasil CIS column (250 mm ×4.6 mm,5 μm) using methanol-0.01 mol/L potassium dihydrogen phosphate solution (adjust pH to 7.0 with sodium hydroxide solution) (30:70) as mobile phase. The flow rate was 1. 0 mL/min and the detection wavelength 360 nm. Results β-alanine showed a good linearity in the range of 3-18 μg/mL and the regression equation was as following: y =0. 0445x + 0. 2010(r = 0. 998 6). The average recovery was 99. 1% with RSD of 1.9%. Conclusion The method is convenient, reliable and sensitive for the quality control of the raw material of pamidronate disodium.
作者 饶春意
出处 《广东药学院学报》 CAS 2009年第1期46-48,共3页 Academic Journal of Guangdong College of Pharmacy
基金 广东省科技计划项目(2008B030301360)
关键词 帕米膦酸二钠 Β-丙氨酸 高效液相色谱法 HPLC pamidronate disodium β-alanine
  • 相关文献

参考文献3

二级参考文献25

  • 1钟永祥,张祥斌.帕米膦酸二钠的临床应用进展[J].中华全科医师杂志,2005,4(1):27-29. 被引量:11
  • 2孔俐文,胡志远,王东凯,黎玲,宋扬,苏娟娟.反相高效液相色谱法测定帕米膦酸二钠的含量[J].中国药房,2007,18(1):60-61. 被引量:5
  • 3申淑景 马智勇 李醒亚.博宁引起呼吸困难2例[J].中国新药杂志,1999,8:561-561. 被引量:2
  • 4Boutsen Y, Jamart J, Esselinckx W, et al. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and caicium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.J Bone Miner Res. 2001.16:104-112. 被引量:1
  • 5Morabito N, Gaudio A, Lasco A, et al. Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postemenopausal osteoporosis. Osteoporos Int,2003,14 :500-506. 被引量:1
  • 6Bartram SA, Peaston RT, Rawlings DJ, et al. A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease. Aliment Phamacol Ther,2003.18 : 1121-1127. 被引量:1
  • 7Senaratne SG, Pirianov G, Mansi JL. Bisphosphonates induce apoptosis in human breast cancer cell lines. J Pediatr Endocrinol Metab ,2002,15 : 163-174. 被引量:1
  • 8Johnston AD. Pathology of metastatic tumors in bone. Clin Orthop,1970,73:8-32. 被引量:1
  • 9Coleman RE, Rubens RD. Bone metastases and breast cancer.Cancer Treat Rev, 1985,12:251-270. 被引量:1
  • 10Horbagyi CN,Theriault RL, Porter L, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytie bone metastases . N Engl J Med , 1996, 335 : 1785-1791. 被引量:1

共引文献13

同被引文献12

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部